These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 513068)

  • 21. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II.
    O'Connor GJ; Baranowski RL; Kurtzman NA
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454
    [No Abstract]   [Full Text] [Related]  

  • 22. The half-life of angiotensin II analogues in the rat, determined from the decay of the pressor response [proceedings].
    Brooks DP; Chapman BJ; Munday KA
    J Physiol; 1977 Feb; 265(1):35P-36P. PubMed ID: 850176
    [No Abstract]   [Full Text] [Related]  

  • 23. Conformation of angiotensin II in aqueous solution. Titration of several peptide analogs and homologs.
    Juliano L; Paiva AC
    Biochemistry; 1974 May; 13(11):2445-50. PubMed ID: 4364780
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin II: dependence of hormone affinity on the electronegativity of a single side chain.
    Guillemette G; Bernier M; Parent P; Leduc R; Escher E
    J Med Chem; 1984 Mar; 27(3):315-20. PubMed ID: 6699877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists.
    Weinstock J; Keenan RM; Samanen J; Hempel J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Gleason JG; Hill DT
    J Med Chem; 1991 Apr; 34(4):1514-7. PubMed ID: 2016730
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
    Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
    J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla.
    Averill DB; Tsuchihashi T; Khosla MC; Ferrario CM
    Brain Res; 1994 Dec; 665(2):245-52. PubMed ID: 7895060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lipophilic character on the biological activity of synthetic angiotensin peptides.
    Nouailhetas VL; Nakaie CR; Juliano L; Paiva AC
    Biochem J; 1977 Sep; 165(3):547-51. PubMed ID: 921765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM; Vaughan ED; Peach MJ; Ayers CR
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drinking and changes in blood pressure in response to precursors, fragments and analogues of angiotensin II in the pigeon Columba livia.
    Evered MD; Fitzsimons JT
    J Physiol; 1981 Jan; 310():353-66. PubMed ID: 6164784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of angiotensin II antagonists with variations in position 5.
    Nyéki O; Szalay KS; Kisfaludy L; Kárpáti E; Szporny L; Makara GB; Varga B
    J Med Chem; 1987 Oct; 30(10):1719-24. PubMed ID: 3656348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonists of angiotensin. Substitution of an aliphatic chain to phenyl ring in position 8.
    Regoli D; Park WK; Rioux F; Chan CS
    Rev Can Biol; 1971 Dec; 30(4):319-29. PubMed ID: 4332582
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential effects of an angiotensin II analogue on pressor and adrenal receptors in the rabbit.
    Steele JM; Lowenstein J
    Circ Res; 1974 Oct; 35(4):592-600. PubMed ID: 4369923
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of responses to angiotensin IV in the pulmonary vascular bed of the cat.
    Cheng DY; DeWitt BJ; Dent EL; Nossaman BD; Kadowitz PJ
    Eur J Pharmacol; 1994 Aug; 261(1-2):223-7. PubMed ID: 8001649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid-phase synthesis of (6-arginine)-, (4-histidine, 6-tyrosine)-, and (8-isoleucine)angiotensins II.
    Khosla MC; Kumar S; Smeby RR; Bumpus FM
    J Med Chem; 1972 Jun; 15(6):627-9. PubMed ID: 4337901
    [No Abstract]   [Full Text] [Related]  

  • 36. Analogues of angiotensin II with restricted conformational freedom, including a new antagonist.
    Turk J; Needleman P; Marshall GR
    Mol Pharmacol; 1976 Mar; 12(2):217-24. PubMed ID: 1264066
    [No Abstract]   [Full Text] [Related]  

  • 37. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sar1Ile7]angiotensin III, a new selective antagonist of the pressor effect of angiotensin III in conscious rats.
    Tabrizchi R; Moore GJ; Pang CC
    Life Sci; 1988; 43(6):537-43. PubMed ID: 3405034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new class of angiotensin II analogs: substitution of sarcosine in position 7.
    Moore G; Oudeman E; Gorman P
    Proc West Pharmacol Soc; 1978; 21():261-6. PubMed ID: 693506
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced pressor response to angiotensin III in spontaneously hypertensive rats: effects of losartan.
    Radhakrishnan R; Sim MK
    Eur J Pharmacol; 1994 Jun; 259(1):87-90. PubMed ID: 7957599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.